SCHEMBL29913009

SCHEMBL29913009

Nc1nccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20099 1.00
Methane SCHEMBL14630339 0.97
SCHEMBL1256526 0.82 PIK3CD (0.37)
SCHEMBL1024624 0.75
SCHEMBL29985108 0.75
SCHEMBL103808 0.75
SCHEMBL11528959 0.71 MAPKAPK2 (0.32)
SCHEMBL12501047 0.71 LMNA (0.48)
SCHEMBL28173312 0.68 MAP4K4 (0.48)
Pyrazine SCHEMBL8836982 0.67 HSP90AA1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024147703-A1 SHP2 INHIBITOR AND USES THEREOF 주식회사 카나프테라퓨틱스 2024-07-11 WO disclosed
EP-4329881-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF Vanqua Bio, Inc. (US) 2024-03-06 EP disclosed
CN-116583577-A Heteroaromatic isothiocyanates 默克专利股份有限公司 2023-08-11 CN disclosed
WO-2022232383-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2022-11-03 WO disclosed